![]() |
市場調查報告書
商品編碼
1662592
2030 年兒科重症加護市場預測:按產品類型、治療類型、年齡層、護理環境和地區進行的全球分析Pediatric Critical Care Market Forecasts to 2030 - Global Analysis By Product Type, Treatment Type, Age Group, Care Settings and By Geography |
根據 Stratistics MRC 的數據,全球兒科重症加護市場預計在 2024 年達到 289 億美元,到 2030 年預計將達到 424 億美元,預測期內的複合年成長率為 6.6%。
兒科重症加護是醫療保健的一個專業領域,致力於為重症新生兒、兒童和青少年提供全面的醫療護理。兒科重症加護室 (PICU) 提供專門護理、高級生命支持和持續監測。這個多學科部門的目標是透過治療嚴重感染疾病、呼吸衰竭、創傷和術後併發症等危及生命的疾病來穩定和增強年輕患者的健康。
根據衛生資源與服務管理局 (HRSA) 2024 年報告,2022 年美國共有 279,194 名基層醫療醫生。
重症患者增加
兒童先天性心臟疾病、呼吸系統疾病、敗血症等嚴重疾病發生率的增加是兒科重症加護市場發展的主要驅動力。診斷工具和醫療技術的進步提高了存活率,並產生了對專門重症加護的需求。此外,人們對早期療育的認知不斷提高以及全球兒科重症加護病房(PICU)數量的增加進一步推動了市場的成長。對更好的醫療基礎設施和資源來管理複雜的兒科病例的需求支持了市場的擴張。
嚴格的法規和核准
監管機構要求進行嚴格的臨床試驗,以確保兒童的安全性和有效性,這導致產品核可延遲。這個過程增加了開發成本,並阻礙了製造商對創新解決方案的投資。此外,各地區缺乏標準化的指導方針,造成了複雜的監管格局,限制了某些市場獲得先進療法的可行性。
兒科重症加護中的遠端醫療
遠端醫療可以實現遠端監控和諮詢,改善醫療服務不足地區獲得專科護理的機會。減少病人轉移的需要並最佳化 PICU 的資源利用率。隨著遠端醫療技術的進步和 COVID-19 大流行期間的廣泛採用,遠端醫療正在成為增強醫療服務的重要工具,尤其是在農村和資源匱乏的地區。
人們對藥品和醫療設備安全的擔憂日益加劇
對兒科重症加護中使用的藥物和醫療設備的安全性的擔憂對市場成長構成了威脅。兒科專用配方有限,導致廣泛的藥物不良反應 (ADR) 和仿單標示外的使用。同樣,缺乏兒科友善醫療設備也增加了治療過程中的風險。這些挑戰需要嚴格的安全標準和針對兒科需求的創新,這可能會延遲產品的上市和採用。
由於住院人數減少和資源重新分配到成人重症監護室,COVID-19 疫情嚴重擾亂了兒科重症加護市場。對感染病毒的恐懼導致兒童無法獲得醫療救治,導致嚴重兒童的治療結果惡化。然而,疫情加速了遠端醫療的普及,使得遠距諮詢和持續照護成為可能。雖然 PICU 入院人數暫時下降,但疫情後的復原工作已引發對醫療保健基礎設施的新一輪投資,從而支持了長期成長。
預計預測期內監測和診斷設備部分將實現最大幅度成長。
監測和診斷設備部分預計將在預測期內佔據最大的市場佔有率,因為它在管理重症兒童方面發揮著至關重要的作用。這些設備提供心率、氧氣水平和血壓等重要參數的即時資料,從而能夠及時干預。該領域的成長得益於非侵入性技術的進步和遠端監控系統的日益普及。它在 PICU 中的廣泛使用確保了準確的診斷和有效的治療計劃,從而鞏固了其在市場上的地位。
預計預測期內心血管疾病領域將以最高的複合年成長率成長。
由於先天性心臟疾病的增加和外科手術的進步,心血管疾病領域預計在預測期內將出現最高的成長率。專門的心臟重症加護病房(CICU)正在不斷建立,以治療需要重症加護的複雜病例。體外膜氧合(ECMO)系統等醫療設備的創新進一步提高了嚴重心血管疾病的存活率,推動了該領域的快速成長。
在預測期內,由於兒科人口龐大且醫療保健投資不斷增加,預計亞太地區將佔據最大的市場佔有率。隨著醫療服務的改善和新生兒護理意識提升,中國和印度等國家的 PICU 入院人數正在增加。政府支持醫療保健基礎設施發展的舉措進一步支持了該地區的發展。全球企業在亞太地區的存在也為該地區的優勢做出了巨大貢獻。
在預測期內,由於醫療技術的快速進步和對專業兒科護理的需求不斷成長,預計亞太地區將呈現最高的複合年成長率。該地區龐大的人口數量和先天性心臟疾病等慢性病發病率的上升也在推動市場擴張。對醫療專業人員培訓計劃的投資和新 PICU 的建立將加強服務的提供,並將確保整個預測期內的強勁成長。
According to Stratistics MRC, the Global Pediatric Critical Care Market is accounted for $28.9 billion in 2024 and is expected to reach $42.4 billion by 2030 growing at a CAGR of 6.6% during the forecast period. A specialty area of medicine called pediatric critical care is dedicated to offering complete medical care to critically ill newborns, kids, and teenagers. It entails specialized treatments, advanced life support, and ongoing monitoring in a pediatric intensive care unit (PICU). The objective of this multidisciplinary field is to stabilize and enhance the health of young patients by treating life-threatening conditions like severe infections, respiratory failure, trauma, and post-surgical complications.
According to the Health Resources and Services Administration (HRSA) 2024 report, there were 279,194 primary care physicians in the U.S. in 2022.
Rising prevalence of pediatric critical conditions
The increasing incidence of critical conditions such as congenital heart diseases, respiratory disorders, and sepsis among children is a major driver of the pediatric critical care market. Advancements in diagnostic tools and medical technologies have improved survival rates, necessitating specialized intensive care. Additionally, rising awareness about early intervention and the growing number of pediatric intensive care units (PICUs) globally further fuel market growth. The demand for better healthcare infrastructure and resources to manage complex pediatric cases underscores the market's expansion.
Stringent regulations and approvals
Regulatory bodies require rigorous clinical trials to ensure safety and efficacy for pediatric use, leading to delays in product approvals. These processes increase development costs, discouraging manufacturers from investing in innovative solutions. Furthermore, the lack of standardized guidelines across regions complicates the regulatory landscape, limiting the availability of advanced treatments in certain markets.
Telemedicine in pediatric critical care
Telemedicine enables remote monitoring and consultation, improving access to specialized care in underserved regions. It reduces the need for patient transfers, optimizing resource utilization in PICUs. With advancements in telehealth technology and increasing adoption during the COVID-19 pandemic, telemedicine is becoming a vital tool for enhancing care delivery, particularly in rural or low-resource settings.
Rising concerns over drug and equipment safety
Concerns regarding the safety of drugs and medical equipment used in pediatric critical care pose a threat to market growth. Adverse drug reactions (ADRs) and off-label drug use are prevalent due to limited pediatric-specific formulations. Similarly, the lack of child-friendly medical devices increases risks during treatment. These challenges necessitate stringent safety standards and innovations tailored to pediatric needs, which can delay product availability and adoption.
The COVID-19 pandemic significantly disrupted the pediatric critical care market due to reduced hospital admissions and resource reallocation towards adult ICUs. Fear of virus exposure led to delayed healthcare access for children, worsening outcomes for critical conditions. However, the pandemic accelerated telemedicine adoption, enabling remote consultations and continuity of care. While PICU admissions declined temporarily, post-pandemic recovery efforts have driven renewed investments in healthcare infrastructure, supporting long-term growth.
The monitoring and diagnostic devices segment is expected to be the largest during the forecast period
The monitoring and diagnostic devices segment is expected to account for the largest market share during the forecast period due to their essential role in managing critically ill children. These devices provide real-time data on vital parameters like heart rate, oxygen levels, and blood pressure, enabling timely interventions. The segment's growth is driven by advancements in non-invasive technologies and increasing adoption of remote monitoring systems. Their widespread use across PICUs ensures accurate diagnosis and effective treatment planning, solidifying their position in the market.
The cardiovascular conditions segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the cardiovascular conditions segment is predicted to witness the highest growth rate due to rising incidences of congenital heart diseases and advancements in surgical interventions. Specialized cardiac intensive care units (CICUs) are increasingly being established to address complex cases requiring critical care. Innovations in medical devices like ECMO (extracorporeal membrane oxygenation) systems further enhance survival rates for severe cardiovascular conditions, driving rapid growth in this segment.
During the forecast period, the Asia Pacific region is expected to hold the largest market share due to its high pediatric population and increasing healthcare investments. Countries like China and India are witnessing rising PICU admissions driven by improved access to healthcare services and awareness about neonatal care. Government initiatives supporting healthcare infrastructure development further bolster regional growth. The presence of global companies expanding their footprint in Asia Pacific also contributes significantly to its dominance.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR owing to rapid advancements in healthcare technologies and growing demand for specialized pediatric care. The region's large population base, coupled with increasing prevalence of chronic conditions like congenital heart diseases, fuels market expansion. Investments in training programs for healthcare professionals and the establishment of new PICUs enhance service delivery, ensuring robust growth throughout the forecast period.
Key players in the market
Some of the key players in Pediatric Critical Care Market include Birmingham Women's and Children's NHS Foundation Trust, The Children's Hospital of Philadelphia, Memorial Sloan Kettering Cancer Center, Great Ormond Street Hospital, The Hospital for Sick Children, Weill Cornell Medicine, Boston Children's Hospital, John Muir Health, Alder Hey Children's NHS Foundation Trust, Ann & Robert H. Lurie Children's Hospital of Chicago, Dragerwerk AG & Co. KGaA, Cardinal Health, Koninklijke Philips N.V., Medtronic and GE Healthcare.
In September 2024, Children's Hospital Association (CHA), Cardinal Health, and Zero Suicide Institute (ZSI) celebrate early success of the Preventing Youth Suicide Collaborative, a collaborative funded by the Cardinal Health Foundation, led by CHA, and informed by ZSI's prevention expertise.
In April 2024, Drager, a global leader in medical and safety technology, announces the launch of Vista 300 in India, a groundbreaking patient monitoring system designed to streamline information flow across hospital departments. The Vista 300 system offers continuous end-to-end data transfer from the patient's bed to the Hospital Information System (HIS), providing medical professionals with access to critical clinical care information along the entire patient pathway, from the Emergency Room (ER) to the Intensive Care Unit (ICU) and Neonatal Intensive Care Unit (NICU).
In July 2023, Medanta group of hospitals, a leading healthcare service provider, announced the launch of Tele-ICU services in India as Medanta e-ICU project, in association with GE HealthCare, a leading global medical technology and digital solutions innovator, with a vision to nurture superspeciality based critical care practices. This association aims to transform healthcare delivery and address the existing gaps in critical care, with high level knowledge transfer via 24x7 Medanta e-ICU Command Centre, powered by cutting edge technology from GE HealthCare that equips both central and bedside medical teams.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.